about
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety studyDiethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasisTolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hoReduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New GuineaHigh prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemicAdvancing Sino-Indian cooperation to combat tropical diseases.The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis.Ensuring supplies of quality diethylcarbamazine citrate (DEC).Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India.
P2860
Q21562277-F1FE3398-00FA-4A13-868F-79650DC0FA52Q24243051-883A3848-A58B-4F2D-A621-C8D5634B62F1Q24793634-5D478EF9-C1FF-4591-9F85-7949618AD4F2Q28478979-32D86364-DBEC-4B61-95E0-4942EE2665D9Q30395591-F6E324D3-AEEE-43A8-82B0-57A8B6498839Q35006505-93E3335A-191F-4D05-9956-414D57E06440Q36377501-7211CF52-227F-4C0D-95E2-5E1907943955Q39639935-21DF7090-DC30-4E57-BF6D-E6AD8DF1F2DAQ39687003-9664987C-32AA-407B-A86D-F2B40CF888D9Q43818412-C10E838F-322E-4927-824D-80DDC48C7C76Q44158169-7524F8B6-FC7C-4842-9F8F-58C21D5A401BQ44384283-F1B84BCB-C974-453C-833F-2D2C87008A71Q44443741-55602BE9-E559-491A-8BD2-0ECA3912E7BBQ45125904-57F37654-7A75-4269-A1C6-07AA1DE6FE0F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Towards elimination of lymphatic filariasis in India.
@ast
Towards elimination of lymphatic filariasis in India.
@en
Towards elimination of lymphatic filariasis in India.
@nl
type
label
Towards elimination of lymphatic filariasis in India.
@ast
Towards elimination of lymphatic filariasis in India.
@en
Towards elimination of lymphatic filariasis in India.
@nl
prefLabel
Towards elimination of lymphatic filariasis in India.
@ast
Towards elimination of lymphatic filariasis in India.
@en
Towards elimination of lymphatic filariasis in India.
@nl
P2093
P1476
Towards elimination of lymphatic filariasis in India.
@en
P2093
P304
P356
10.1016/S1471-4922(01)02056-6
P577
2001-10-01T00:00:00Z